Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.34 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL165933 | 1.00 | MPI (0.36) | MPIUSP2SLCO1B1PAX8LMNA | |
| SCHEMBL7155133 | 1.00 | MPI (0.36) | MPIUSP2SLCO1B1PAX8LMNA | |
| SCHEMBL181949 | 1.00 | MPI (0.36) | MPIUSP2SLCO1B1PAX8LMNA | |
| SCHEMBL10699689 | 0.88 | MPI (0.33) | MPIUSP2SLCO1B1PAX8 | |
| SCHEMBL9078408 | 0.88 | MPI (0.33) | MPIUSP2SLCO1B1PAX8 | |
| SCHEMBL705391 | 0.87 | PAX8 (0.36) | MPIUSP2SLCO1B1PAX8 | |
| SCHEMBL5351083 | 0.83 | ITPR3 (0.31) | — | |
| SCHEMBL177758 | 0.83 | MPI (0.46) | MPILMNAL3MBTL1TDP1 | |
| SCHEMBL5972505 | 0.83 | MPI (0.46) | MPILMNAL3MBTL1TDP1 | |
| SCHEMBL1922060 | 0.83 | MPI (0.46) | MPILMNAL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 570 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026085839-A1 | COMPOSITION AND METHOD FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2026-04-30 | — | — | WO | claimed |
| CN-222349015-U | Device for producing D-psicose by utilizing fructose solution | 东台市浩瑞生物科技有限公司 | 2025-01-14 | — | — | CN | claimed |
| CN-112851723-B | Continuous preparation device and process for glucosamine sulfate or phosphate compound | 厦门海洋本草绿色科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| CN-118389625-A | Method for co-producing glucosamine hydrochloride and D-psicose from fructose solution | 诸城市浩天生物科技有限公司 | 2024-07-26 | — | — | CN | claimed |
| CN-117586443-A | Polyacrylamide glucosamine ester, and preparation method and application thereof | 中国科学院福建物质结构研究所 | 2024-02-23 | — | — | CN | claimed |
| WO-2023219437-A1 | METHOD FOR PRODUCING LACTO-N-TETRAOSE AND LACTO-N-NEOTETRAOSE USING CORYNEBACTERIUM GLUTAMICUM | (주)에이피테크놀로지 | 2023-11-16 | — | — | WO | claimed |
| CN-116323927-A | Cell production of di-and/or oligosaccharides | 因比奥斯公司 | 2023-06-23 | — | — | CN | claimed |
| CN-115804451-A | Composition beneficial to increase of bone density and application of composition in food | 广州欣盛通健康管理科技有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-112458034-B | Recombinant escherichia coli constructed by genetic engineering and method for biologically synthesizing 6' -sialyllactose | 南开大学 | 2023-01-24 | — | — | CN | claimed |
| CN-112280727-B | Recombinant escherichia coli for synthesizing lactyl-N-trisaccharide and construction method and application thereof | 江南大学 | 2022-12-30 | — | — | CN | claimed |
| US-6911326-B1 | GlmU polypeptide and DNA encoding the polypeptide | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2005-06-28 | — | — | US | claimed |
| WO-2005056570-A2 | PRODUCTION OF AMINO SUGARS | CARGILL, INC. (US) | 2005-06-23 | — | — | WO | claimed |
| US-20050014720-A1 | Process for the preparation of glucosamine salts | BIOBERICA, S.A. (ES) | 2005-01-20 | — | — | US | claimed |
| US-20040185035-A1 | Dietary supplements and methods for treating pain and inflammation | MELALEUCA, INC., AN IDAHO CORPORATION | 2004-09-23 | — | — | US | claimed |
| EP-1455800-A1 | PROCESS FOR THE PREPARATION OF GLUCOSAMINE SALTS | BIOIBERICA, S.A. (ES) | 2004-09-15 | — | — | EP | claimed |
| US-6713096-B2 | FOR REDUCING PAIN, INFLAMMATION, STIFFNESS, OR DISCOMFORT IN A MAMMAL | MELALEUCA, INC. | 2004-03-30 | — | — | US | claimed |
| US-20030143292-A1 | For reducing pain, inflammation, stiffness, or discomfort in a mammal | MELALEUCA, INC. | 2003-07-31 | — | — | US | claimed |
| WO-2003053448-A1 | PROCESS FOR THE PREPARATION OF GLUCOSAMINE SALTS | BIOIBERICA, S.A. (ES) | 2003-07-03 | — | — | WO | claimed |
| EP-1234882-A1 | GlmU POLYPEPTIDE AND DNA ENCODING THE POLYPEPTIDE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-08-28 | — | — | EP | claimed |
| US-20020064836-A1 | PROCESSES FOR PRODUCING SUGAR NUCLEOTIDES AND COMPLEX CARBOHYDRATES | KYOWA HAKKO BIO CO., LTD. (JP) | 2002-05-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030143292-A1 | For reducing pain, inflammation, stiffness, or discomfort in a mammal | TNF, IL6, IL1B | MPI 2440/4885USP2 3641/4885SLCO1B1 2840/4885 |
| US-20040185035-A1 | Dietary supplements and methods for treating pain and inflammation | IL6, TNF, IL1B | MPI 2507/4885USP2 3164/4885SLCO1B1 2720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.